Search results for "Highlights"


 
Results 241 - 250 of about 443 for "Highlights".
Sort by: Relevance | Newest | Oldest

Rates of diabetes-related ESRD appear to decrease in U.S., Puerto Rico

From 2000 to 2014, the age-standardized incidence of end-stage renal disease (ESRD) attributed to diabetes decreased from 260.2 to 173.9 per 100,000 diabetic population.
https://diabetes.acponline.org/archives/2017/11/10/3.htm
10 Nov 2017

Minority of patients with type 1 diabetes achieve ADA goals for glycemic control, study finds

Despite increasing adoption of insulin pumps and continuous glucose monitors, control of HbA1c hasn't necessarily improved, the authors noted.
https://diabetes.acponline.org/archives/2019/02/08/1.htm
8 Feb 2019

Risk score may help predict future glycemic control after new diagnosis of diabetes

The most important predictors of the trajectory of glucose control were body mass index and levels of HbA1c and triglycerides, according to the study of registry data from the Netherlands.
https://diabetes.acponline.org/archives/2017/12/08/3.htm
8 Dec 2017

Dapagliflozin appears effective as adjunct therapy in patients with type 1 diabetes

Patients with type 1 diabetes taking dapagliflozin for 24 weeks had lower HbA1c level, body weight, and insulin dose than those on placebo, according to the industry-funded study.
https://diabetes.acponline.org/archives/2017/10/13/2.htm
13 Oct 2017

Type 1 diabetes associated with increased atrial fibrillation risk, particularly in women

Risk of atrial fibrillation increased with worse glycemic control and renal complications. Among patients with normoalbuminuria, researchers found no excess risk of atrial fibrillation with an HbA1c less than 9.7% for men or 8.8% for women.
https://diabetes.acponline.org/archives/2017/09/08/2.htm
8 Sep 2017

Tool may help stratify risk for hypoglycemia-related ED and hospital use

The hypoglycemia risk stratification tool is based on six variables: previous episodes of hypoglycemia-related hospital utilization, insulin use, sulfonylurea use, ED use in the previous year, chronic kidney disease stage, and age.
https://diabetes.acponline.org/archives/2017/09/08/3.htm
8 Sep 2017

Insulin pumps reduced ketoacidosis, hypoglycemia in young patients with type 1 diabetes

The results provide further evidence that insulin pump therapy is safe and effective, even in routine diabetes care for unselected patients, according to the study authors.
https://diabetes.acponline.org/archives/2017/10/13/3.htm
13 Oct 2017

Updated ADA standards of diabetes care include focus on cardiovascular issues

The American Diabetes Association (ADA) recommends assessment of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in patients with diabetes and discusses appropriate use of the ASCVD calculator.
https://diabetes.acponline.org/archives/2019/01/11/1.htm
11 Jan 2019

Cardiovascular disease and mortality appear lower in patients on SGLT2 inhibitors

The observational analysis compared sodium-glucose co-transporter-2 (SGLT2) inhibitors with other glucose-lowering drugs in patients with type 2 diabetes in Denmark, Norway, and Sweden.
https://diabetes.acponline.org/archives/2017/08/11/3.htm
11 Aug 2017

Glucose self-monitoring had no effect on glycemic control in non–insulin-treated type 2 diabetes

Although it would seem to make sense that routine glucose self-monitoring provides better outcomes, this long-held belief is not supported by the data, said an editor's note accompanying the study.
https://diabetes.acponline.org/archives/2017/07/14/1.htm
14 Jul 2017

Result Page: Prev   20   21   22   23   24   25   26   27   28   29   Next